Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Georgetown University
Deal Watch: Fresenius Buyout Of Akorn Potentially Threatened By Data Integrity Issues
AstraZeneca takes second license of antisense candidate under 2012 pact with Ionis, this time for kidney disease. Aldeyra is working with J&J on novel immune-modulating drugs for systemic inflammatory conditions.
Start-Up Quarterly Statistics, Q2 2016
A review of biopharma start-up dealmaking and financing from April through June 2016, based on data from Strategic Transactions.
Deals Shaping The Medical Industry, July 2016
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in June 2016.
Endovascular Thrombectomy Shows No Benefit Over Standard Of Care In MR RESCUE
A National Institutes of Health-sponsored trial appears to dash hopes that CT or MR imaging can help select patients for acute stroke treatment with first-generation thrombus retrieval systems.
- Academic and Research Institutions
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.